You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IDH-mutated diffuse grade II astrocytoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)

Recruiting
  • Oligodendroglioma
  • +2 more
  • Radiation therapy
  • Oslo, Norway
    Oslo University Hospital
Jan 14, 2022

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

Active, not recruiting
  • Astrocytoma
  • Glioblastoma
  • Jacksonville, Florida
  • +8 more
Dec 14, 2022

Glioma, Pilocytic Astrocytoma, Pilomyxoid Astrocytoma Trial in Rochester, Memphis (Hippocampal-avoidance proton therapy)

Recruiting
  • Glioma
  • +6 more
  • Hippocampal-avoidance proton therapy
  • Rochester, Minnesota
  • +1 more
Aug 18, 2022

WHO Grade II Glioma Trial in Japan (DS-1001b)

Active, not recruiting
  • WHO Grade II Glioma
  • Nagoya, Aichi, Japan
  • +10 more
Feb 3, 2022

High Grade Glioma, Brain Cancer Trial in France (Nivolumab)

Completed
  • High Grade Glioma
  • Brain Cancer
  • Bordeaux, France
  • +6 more
Dec 13, 2021

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Brain Cancer Trial in Canada, United States (cetuximab in conjunction with external beam radiation therapy, followed by

    Completed
    Has Results
    • Brain Cancer
    • cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
    • Phoenix, Arizona
    • +11 more
    Mar 2, 2022

    Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes

    Recruiting
    • Astrocytoma, Grade II
    • +3 more
      • Rotterdam, Zuid Holland, Netherlands
      • +4 more
      Mar 23, 2020

      Adult Brain Tumor, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma Trial in Philadelphia (radiation, procedure, other)

      Completed
      • Adult Brain Tumor
      • +11 more
      • proton beam radiation therapy
      • +2 more
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of The University of Pennsylvania
      Dec 8, 2020

      Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas

      Completed
      • Glioma
        • Montpellier, France
          Uh Montpellier
        Jun 4, 2020

        Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in Los Angeles (tumor lysate-pulsed autologous

        Completed
        Has Results
        • Adult Diffuse Astrocytoma
        • +4 more
        • tumor lysate-pulsed autologous dendritic cell vaccine
        • laboratory biomarker analysis
        • Los Angeles, California
          Jonsson Comprehensive Cancer Center
        Oct 14, 2020

        Space Occupying Lesions of the Brain

        Recruiting
        • Brain Tumor
        • +2 more
        • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
        • Bern, Switzerland
          Institute for Diagnostic and Interventional Neuroradiology, Univ
        Jan 26, 2023

        Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

        Recruiting
        • Recurrent IDH1/2 Mutated Glioma
        • Paris, France
          Pitie Salpetriere Hospital
        Aug 29, 2022

        Glioma Trial in Melbourne (Biopsy, Part A: AB-218, Surgery (maximal resection))

        Recruiting
        • Glioma
        • Biopsy
        • +3 more
        • Melbourne, Victoria, Australia
          Royal Melbourne Hospital
        Oct 11, 2022

        Clinical Development of Cancer-Specific MRS Biomarkers in

        Completed
        • Malignant Gliomas
        • +2 more
        • 3 Tesla scanning
        • Dallas, Texas
          UT Southwestern Medical Center
        Jan 19, 2022

        Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in San Francisco (Everolimus, Archival Tissue

        Completed
        Has Results
        • Adult Diffuse Astrocytoma
        • +4 more
        • San Francisco, California
          University of California, San Francisco
        Jul 24, 2020

        Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

        Recruiting
        • Astrocytoma, Grade IV
        • +7 more
          • Valencia, Spain
            Biomedical Data Science Lab. Universitat Politècnica de València
          May 11, 2022

          Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)

          Not yet recruiting
          • Brain Tumor
          • Cancer
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023

          Glioma Trial in Paris (MRI)

          Not yet recruiting
          • Glioma
          • MRI
          • Paris, France
            Pitié-Salpetrière Hospital
          Jan 27, 2023

          Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)

          Active, not recruiting
          • Grade III Astrocytoma
          • +3 more
          • Saint Louis, Missouri
            Washington University School of Medicine
          Jun 9, 2022

          Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States

          Active, not recruiting
          • Diffuse Intrinsic Pontine Glioma
          • +4 more
          • Los Angeles, California
          • +18 more
          Aug 16, 2022

          Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

          Active, not recruiting
          • Oligodendroglioma
          • +5 more
          • GBM6-AD and poly-ICLC before and after surgery
          • GBM6-AD and poly-ICLC after surgery only
          • San Francisco, California
            University of California
          Sep 20, 2022

          Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

          Not yet recruiting
          • Diffuse Astrocytoma, IDH-Mutant
          • +20 more
          • NEO212 Oral Capsule
          • +8 more
          • (no location specified)
          Sep 18, 2023